AYTU

Aytu Biopharma Inc

• TipRanks·4d ago

  Aytu BioScience Bets on EXXUA Amid Legacy Declines

• PUBT·5d ago

  Aytu BioPharma to present at Lytham Partners Spring Investor Conference

• TipRanks·05/15 13:28

  Aytu BioScience (AYTU) Gets a Buy from Maxim Group

• TipRanks·05/15 00:31

  Aytu BioScience Earnings Call: EXXUA Drives Transition

• TipRanks·05/14 13:21

  Lake Street Sticks to Its Buy Rating for Aytu BioScience (AYTU)

• TipRanks·05/14 13:21

  Analysts Offer Insights on Healthcare Companies: Assertio Therapeutics (ASRT), Aytu BioScience (AYTU) and Oruka Therapeutics (ORKA)

• Seeking Alpha·05/14 01:31

  Aytu outlines $6M-$7M quarterly sales and marketing spend range as EXXUA scripts rise to over 920 in April

• PUBT·05/13 21:42

  Aytu Biopharma posts corporate presentation highlighting CNS portfolio, including EXXUA for depression

• Benzinga·05/13 21:39

  Full Transcript: Aytu BioPharma Q3 2026 Earnings Call

• TipRanks·05/13 21:11

  Aytu BioPharma reports Q3 EPS (53c), consensus (43c)

• Reuters·05/13 20:25

  Aytu BioPharma Q3 revenue falls amid EXXUA launch

• PUBT·05/13 20:08

  Aytu Biopharma FY26 Q3 turns to $5.6 million net loss; revenue drops to $12.4 million

• Benzinga·05/13 20:07

  Aytu BioPharma Q3 EPS $(0.53) Misses $(0.51) Estimate, Sales $12.411M Beat $12.053M Estimate

• Reuters·05/13 20:05

  AYTU BIOPHARMA Q3 EPS USD -0.53

• Seeking Alpha·05/13 14:00

  Here are the major earnings after the close Wednesday